home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Revance Therapeutics, Inc. - Common Stock (NQ:RVNC)

3.650 UNCHANGED

Last Price Updated: 4:00 PM EST, Feb 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Revance Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Pinterest To Rally Around 45%? Here Are 10 Other Analyst Forecasts For Wednesday ↗

September 20, 2023

Rosenblatt increased the price target for Pinterest, Inc. (NYSE: PINS) from $35 to $38. Rosenblatt analyst Barton Crockett maintained a Buy rating. Pinterest shares rose 3.2% to close at $26.21 on...

Via Benzinga

Why Fresh Tracks Therapeutics Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket ↗

September 20, 2023

Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 70.2% to $0.8937 in pre-market trading after falling 10% on Tuesday.

Via Benzinga

The Latest Analyst Ratings for Revance Therapeutics ↗

September 20, 2023

Via Benzinga

Instacart, ARS Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

September 20, 2023

U.S. stock futures traded higher this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

What's Going On With Botox Rival Revance Therapeutics' Stock Today? ↗

September 19, 2023

Revance Therapeutics Inc (NASDAQ: RVNC) commenced a plan to exit the

Via Benzinga

Where Revance Therapeutics Stands With Analysts ↗

August 09, 2023

Via Benzinga

Earnings Preview: Revance Therapeutics ↗

August 07, 2023

Via Benzinga

Dow Falls 150 Points; AutoZone Earnings Top Views ↗

September 19, 2023

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling more than 150 points on Tuesday. The Dow traded down 0.48% to 34,457.36 while the NASDAQ fell 0.28% to 13,672.29. The S&P...

Via Benzinga

Topics Stocks

Stocks That Hit 52-Week Lows On Tuesday ↗

September 19, 2023

During Tuesday's session, 275 companies made new 52-week lows.

Via Benzinga

What 5 Analyst Ratings Have To Say About Revance Therapeutics ↗

July 11, 2023

Via Benzinga

Analyst Expectations for Revance Therapeutics's Future ↗

June 07, 2023

Via Benzinga

Why Terran Orbital Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

September 19, 2023

Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 124.2% to $0.1697 after falling 15% on Monday.

Via Benzinga

Crude Oil Rises Over 1%; Revance Therapeutics Shares Plummet ↗

September 19, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones falling more than 200 points on Tuesday. The Dow traded down 0.69% to 34,384.29 while the NASDAQ fell 0.82% to 13,597.78. The S&P 500...

Via Benzinga

Topics Stocks

Former IBD 50 Stock Revance Implodes As Its 'Prestige' Plan Goes Up In Smoke ↗

September 19, 2023

The company is still figuring out how to gain share in a market topped by AbbVie.

Via Investor's Business Daily

Markets Open Lower; US Housing Starts Fall In August ↗

September 19, 2023

U.S. stocks traded lower this morning, with the Dow Jones falling around 40 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.12% to 34,581.70 while the NASDAQ fell 0.33%...

Via Benzinga

Topics Stocks

Revance Provides Corporate Update at Investor Day

September 19, 2023

From Revance Therapeutics, Inc.

Via Business Wire

3 Healthcare Stocks to Sell in September Before They Crash & Burn ↗

September 06, 2023

The prognosis for these healthcare stocks isn't optimistic so plan to sell them this month before they get worse.

Via InvestorPlace

3 Very Oversold Biotech Stocks to Buy Right Now ↗

August 29, 2023

These biotech stocks have tumbled a great deal in recent months, but their long-term outlooks remain quite strong.

Via InvestorPlace

3 Very Oversold Pharma Stocks to Buy Right Now ↗

August 24, 2023

Oversold pharma stocks have great total return potential. In this article, we list some of the best to buy.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Monday ↗

September 11, 2023

Monday's session saw 175 companies set new 52-week lows.

Via Benzinga

Revance to Host Investor Day on September 19, 2023

August 22, 2023

From Revance Therapeutics, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Friday ↗

September 08, 2023

Friday's session saw 225 companies set new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2023 ↗

August 16, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

September 07, 2023

On Thursday, 283 companies set new 52-week lows.

Via Benzinga

How Revance Is Taking A Page Out Of AbbVie's Botox Playbook ↗

August 14, 2023

The company sells a cosmetic treatment. Now, it's bridging into neuroscience.

Via Investor's Business Daily

U.S. FDA Approves First Therapeutic Indication for Revance’s DAXXIFY® (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical Dystonia

August 14, 2023

From Revance Therapeutics, Inc.

Via Business Wire

Revance Reports Second Quarter 2023 Financial Results, Provides Corporate Update

August 08, 2023

From Revance Therapeutics, Inc.

Via Business Wire

Revance to Release Second Quarter 2023 Financial Results on Tuesday, August 8, 2023

August 01, 2023

From Revance Therapeutics, Inc.

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

July 12, 2023

Via Benzinga

7 Healthcare Stocks to Make You the Millionaire Next Door ↗

June 21, 2023

For investors who want to greatly increase their wealth in the long term, these are the best healthcare stocks to buy.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com